| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.32 | 9e-08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.23 | 0.0007 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.22 | 0.001 |